Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes. New England Journal of Medicine #ACC25
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings.…
Two plant extracts with potential as GLP-1 agonist weight loss pills are identified by AI-based analysis
Two plant compounds with potential as GLP-1 agonist weight loss pills have been identified in an AI (artificial intelligence)-based study, the European Congress on Obesity (ECO 2024) (Venice 12-15 May),…